# ADR-005: Audit & Traceability Strategy

**Status:** Accepted (Baseline v1.0)  
**Date:** 2026-07-05  
**Owner:** Engineering Governance  
**Version:** 1.0.0  
**Review Frequency:** Annual or upon major architectural change  
**Next Review:** 2027-07-05  

---

## 1. Context & Problem Statement
Pharma AI is a safety-critical CDSS. Regulatory compliance and clinical accountability require that every system decision, data ingestion, and quality assessment be fully auditable and traceable. Without a formalized audit and traceability strategy, proving clinical safety becomes impossible during regulatory reviews or incident investigations.

## 2. Decision Statement (Binding)
**Pharma AI SHALL implement a standardized, immutable Audit and Traceability framework. Every pipeline execution, release decision, and clinical context generation SHALL be assigned a unique `RunID` and `CorrelationID`. All audit artifacts SHALL be stored in a machine-readable JSON format, versioned, and retained according to the defined lifecycle policy. Every production release SHALL be accompanied by exactly one immutable Audit Package.**

## 3. Decision Rationale
* **Accountability:** Establishes a clear chain of custody for clinical data.
* **Incident Investigation:** Enables post-mortem analysis of clinical safety issues.
* **Compliance:** Meets regulatory requirements for system auditability in clinical environments.
* **Deterministic Replay:** Allows re-running of specific pipeline states for troubleshooting.

## 4. Audit Package Definition (Mandatory for Release)
Every production release SHALL bundle the following artifacts:
* `Validation Report`
* `Quality Gate Report`
* `Policy Snapshot`
* `Configuration Snapshot` (quality_config, validation_rules)
* `ADR Baseline Version`
* `Release Metadata`
* `Integrity Hash` (Cryptographic signature)

## 5. Audit Schema (Minimum Fields)
Every audit event MUST contain:
* `RunID`, `CorrelationID`, `Timestamp`
* `Component`, `EventType` (Import, Validation, RepoLoad, ContextBuild, QualityGate, Release, Exception, Review)
* `Severity`, `Result`, `PolicyVersion`, `ValidationVersion`, `ADRVersion`

## 6. Traceability Chain
Raw Data → Validation → Repository → Clinical Context → Prompt Builder → AI Response → Immutable Audit Report.

## 7. Retention & Integrity
* **Hot Storage:** Immediate access (latest 5 runs).
* **Cold Storage:** 7 years (regulatory requirement).
* **Integrity:** All audit records must be WORM (Write-Once-Read-Many) compliant and digitally hashed.

## 8. Non-Functional Requirements
* **Immutability:** Audit records must be tamper-proof.
* **Traceability:** 100% of clinical outputs map to an input validation report.
* **Determinism:** Same input, same audit output.
* **Asynchronous Logging:** Logging must not block pipeline performance.

## 9. Success Criteria
* 100% of pipeline executions generate a traceable `RunID`.
* Every production release has exactly one immutable Audit Package.
* Audit artifacts pass integrity checks via cryptographic hashes.

## 10. Governance & Impact
* **Impacted Components:** `QualityGate`, `PolicyEngine`, `AuditSystem`, `ClinicalContext`.
* **Governance Impact:** Requires compliance with `release_policy.md` and `clinical_policy.md`.
* **Related Documents:** ADR-001, ADR-002, ADR-003, ADR-004.

## 11. Open Questions
* Evaluation of future integration with external distributed tracing (e.g., OpenTelemetry) for cross-service observability.
* Definition of the "Clinical Certificate of Health" format for external regulators.

## 12. Scope & Out of Scope
* **In Scope:** Audit records, Traceability, Run identifiers, Retention, Audit Package generation.
* **Out of Scope:** SIEM integration, Cloud logging platforms, Monitoring dashboards, External observability tooling.